Literature DB >> 17034523

Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up.

N H Cox1.   

Abstract

BACKGROUND: Cellulitis of the lower leg is a common problem with considerable morbidity. Risk factors are well identified but the relationship between consequences of cellulitis and further episodes is less well understood.
OBJECTIVES: To review risk factors, treatment and complications in patients with lower leg cellulitis, to determine the frequency of long-term complications and of further episodes, and any relationship between them, and to consider the likely impact of preventive strategies based on these results.
METHODS: Patients with ascending, presumed streptococcal, cellulitis of the lower leg were identified retrospectively from hospital coding. Hospital records, together with questionnaires to both general practitioners and patients, were used to record subsequent complications and identifiable risk factors for further episodes.
RESULTS: Of 171 patients, 81 (47%) had recurrent episodes and 79 (46%) had chronic oedema. The concurrence of these two factors was strongly correlated (P < 0.0002). Based on 143 completed questionnaires, oedema was apparently due to or persistently asymmetrical after the cellulitic episode in 52 (37%), and 19 (13%) had ulceration attributed to, rather than causing, cellulitis. Of those with three or more episodes, half did not lead to hospital admission. Toeweb maceration was reported in only 15% of questionnaires. Use of antibiotic treatment for more than 28 days was associated with a reduced risk of leg ulceration or of prolonged oedema compared with shorter courses, but neither difference was statistically significant.
CONCLUSIONS: This study demonstrates that the true frequency of postcellulitic oedema, as well as that of further episodes, is probably underestimated. Furthermore, there is a strong association between these factors, each of which is both a risk factor for, and a consequence of, each other, and for which intervention (reduction of oedema or more prolonged antibiotic therapy) may reduce the risk of recurrent infection. By contrast, self-reporting of toeweb maceration is low, so attempts to reduce the risk of recurrent cellulitis by treatment of tinea pedis or bacterial intertrigo may fail.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17034523     DOI: 10.1111/j.1365-2133.2006.07419.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

1.  Recurrent cellulitis: risk factors, etiology, pathogenesis and treatment.

Authors:  Maciej Piotr Chlebicki; Choon Chiat Oh
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

Review 2.  Interventions for cellulitis and erysipelas.

Authors:  Sally A Kilburn; Peter Featherstone; Bernie Higgins; Richard Brindle
Journal:  Cochrane Database Syst Rev       Date:  2010-06-16

3.  Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network's PATCH II trial.

Authors:  Kim Thomas; Angela Crook; Katharine Foster; James Mason; Joanne Chalmers; John Bourke; Adam Ferguson; Nick Level; Andrew Nunn; Hywel Williams
Journal:  Br J Dermatol       Date:  2011-12-06       Impact factor: 9.302

4.  Treatment of Recurrent Severe Cellulitis with a Pill in Pocket Approach.

Authors:  James B Doub
Journal:  Infect Chemother       Date:  2022-01-14

5.  The risk factors of lower limb cellulitis: A case-control study in a tertiary centre.

Authors:  M N Norazirah; I S Khor; J Adawiyah; A M Tamil; M N Azmawati
Journal:  Malays Fam Physician       Date:  2020-03-18

6.  Spontaneous compartment syndrome of the forearm in association with nephrotic syndrome and transient bacteremia.

Authors:  H Chim; Ht Soltanian
Journal:  J Surg Case Rep       Date:  2012-08-01

7.  Prophylactic antibiotics to prevent cellulitis of the leg: economic analysis of the PATCH I & II trials.

Authors:  James M Mason; Kim S Thomas; Angela M Crook; Katharine A Foster; Joanne R Chalmers; Andrew J Nunn; Hywel C Williams
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

8.  Recurrent erysipelas--risk factors and clinical presentation.

Authors:  Malin Inghammar; Magnus Rasmussen; Adam Linder
Journal:  BMC Infect Dis       Date:  2014-05-18       Impact factor: 3.090

9.  Daptomycin-Based 3 Week Treatment Scheme for the First Cellulitis Episode: Low Recurrence Rate Indicative of Decreased Recurrence Propensity?

Authors:  Ioannis D Bassukas; Ioannis Chaniotakis; Georgios Gaitanis
Journal:  Dermatol Ther (Heidelb)       Date:  2016-02-02

10.  Cellulitis in aged persons: a neglected infection in the literature.

Authors:  Anis Mzabi; Wafa Marrakchi; Zeineb Alaya; Fatma Ben Fredj; Amel Rezgui; Elyès Bouajina; Chedia Laouani Kechrid
Journal:  Pan Afr Med J       Date:  2017-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.